
GeneDx Investors File Class Action Following 49% Stock Price Collapse
A 49% plunge in GeneDx Holdings stock has triggered a securities class action lawsuit, as investors allege the company misled them regarding the financial health of its Fabric Genomics acquisition and core diagnostic business. The legal action follows a disastrous Q1 2026 report that wiped out nearly all value from a recent purchase.
























